Archive for the ‘Anti-inflammatory’ tag
Acuvail – latest shape – full-size version
Click on image to view the full-size version as seen on AdPharm.
The latest shape in NSAID therapy
For inflammation and pain after cataract surgery
The ketorolac molecule enhanced, the NSAID advanced.
Optimal outcomes, enhanced patient comfort, and simple BID dosing.

Brand name: Acuvail
Generic name/category: ketorolac tromethamine ophthalmic solution, nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use
Company: Allergan
Country/Market: USA, North America
Indication(s)/use: pain and inflammation following cataract surgery
Target: Healthcare Professionals (HCP)
Tagline: Your Next NSAID
Medium: print ad
Size/duration: Single-page
Publication/Aired: Ophtalmology Times – January 2010
To see all of this brand’s ads on AdPharm, click here
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Colcrys – refined tough
Tough as ever, but a bit more refined
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Naprosyn
![]()
Archives Of Family Medicine – November 1992
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Motrin – Sniffs Out
![]()
Sniffs out nasal congestion.
Motrin targets your cold & sinus symptoms fast.
-Targets your nasal congestion
-Targets your fever
-Targets your sinus pain

To see all of the ads from this campaign, click here

Brand name: Motrin
Generic name/category: Ibuprofen, Non-steroidal anti-inflammatory drugs (NSAID)
Company: McNeil
Country/Market: Canada, North America
Indication(s)/use: Multi-symptom cold medicine
Target: Consumers (DTC)
Tagline: Motrin targets your cold & sinus symptoms fast
Medium: Print ad
Size/duration: Single-page
Publication/Aired: Maclean’s – December 14, 2009
To see all of this brand’s ads on AdPharm, click here

From Wikipedia:
Ibuprofen (INN) is a non-steroidal anti-inflammatory drug (NSAID) originally marketed as Brufen, and since then under various other trademarks (see tradenames section), most notably Nurofen, Advil and Motrin. It is used for relief of symptoms of arthritis, primary dysmenorrhea, fever, and as an analgesic, especially where there is an inflammatory component. Ibuprofen is known to have an antiplatelet effect, though it is relatively mild and short-lived when compared with that of aspirin or other better-known antiplatelet drugs. Ibuprofen is a core medicine in the World Health Organization’s “Essential Drugs List”, which is a list of minimum medical needs for a basic health care system.
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
Enbrel web banner
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Enbrel web banner
Click here to see it on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Treximet – head off
Click on image for original file provided by AdPharm
“My migraines are so excruciating I just want to take my head off.”
Treximet is superior to the ingredient in Imitrex tablets at relieving migraine pain.

Brand name: Treximet
Generic name/category: sumatriptan and naproxen, triptan, nonsteroidal anti-inflammatory drugs (NSAIDs)
Company: GlaxoSmithKline (GSK)
Country/Market: USA, North America
Indication(s)/use: Migraine
Target: Consumers (DTC)
Tagline: My migraines are so excruciating I just want to take my head off
Medium: Print ad
Size/duration: single-page
Publication/Aired: Woman’s Day – November 2009
To see all of this brand’s ads on AdPharm, click here

Treximet (formerly known as Trexima) is a medication manufactured by GlaxoSmithKline and POZEN Pharmaceutical Development Company for the treatment of migraines.
It combines sumatriptan (as the succinate), a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist and naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs), to provide better relief than plain sumatriptan 85 mg, (ie: Imitrex) and anti-inflammatory painkiller, naproxen sodium (the active ingredient in Aleve and Naprosyn) 500 mg, alone would do.
As seen on AdPharm,the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.





